Table 1 Patients selected for S. aureus protein array analysis.

Patient ID	Age	Gender	S. aureus cohort	Other medical conditions	Prior S. aureus infection^	Prior antibiotic course	Days Infected Prior to Visit 1*	Days from Visit 1 to Visit 2	Days from Visit 1 to Visit 3
SSTI 1	54	Male	SSTI	Seizures, HCV	No	No	3	37	178
SSTI 2	25	Male	SSTI	None	No	Yes	5	48	195
SSTI 3	61	Male	SSTI	HCV, pulmonary fibrosis, hypothyroidism	No	No	3	39	207
SSTI 4	50	Male	SSTI	None	No	No	4	41	173
PJI 1	63	Male	Prosthetic Joint (PJI)	Peripheral vascular disease, chronic liver failure, ulcerative colitis, alcoholic cirrhosis, recurrent C. difficile	N/A	N/A	N/A	45	183
PHO 1	9	Male	Septic Arthritis (PHO)	Eczema	N/A	N/A	N/A	27	190
PHO 2	11	Male	Osteomylitis (PHO)	None	N/A	N/A	N/A	41	223

Patient identification numbers, as well as their age, gender, S. aureus proven syndrome, any co-morbid medical conditions are included for all patients selected for the protein array, in addition to the number of days between acute clinical presentation and both the short-term and long-term follow-up visits. Patients in the SSTI cohort provided additional information such as prior and subsequent S. aureus infections or antibiotic courses prior to enrollment, as well as patient-reported duration of symptoms that preceded the day of enrollment. N/A: Data not available. ^This designation was assigned based on the patient’s statement that there was no history provided of an infection requiring attention from a healthcare professional, and a course of antibiotics. *Patient reported, days with symptoms prior to hospital visit.

Quick links

Search